Health data company Truveta announced $320 million in fresh funding and an ambitious new initiative to create a giant genomic dataset. The new investment -which comes from 17 health systems, Illumina, and Regeneron -pushes Truveta's valuation above $1 billion, making it the latest unicorn to emerge from the Seattle region.